Hypercholesterolemia, Autosomal Dominant
5 clinical trials · Condition
◉ Watch Hypercholesterolemia, Autosomal Dominant
| Record | Firm | Date |
|---|---|---|
| Genetic Testing and Motivational Counseling for FH (NCT04656028) | National Medical Research Center for Therapy and Preventive Medicine | 2020-06-15 |
| An Open-label Extension Study to Assess the Long-term Safety and Efficacy of ISIS 301012 (Mipomersen) in Patients With Familial Hypercholesterolemia or Severe-Hypercholesterolemia (NCT00694109) | Kastle Therapeutics, LLC | 2008-04-01 |
| Study to Assess the Safety and Efficacy of ISIS 301012 (Mipomersen) in Homozygous Familial Hypercholesterolemia (NCT00607373) | Kastle Therapeutics, LLC | 2007-07-01 |
| Open Label Extension of ISIS 301012 (Mipomersen) to Treat Familial Hypercholesterolemia (NCT00477594) | Kastle Therapeutics, LLC | 2007-05-01 |
Track Hypercholesterolemia, Autosomal Dominant automatically
Every clearance here is in the API, with alerts when new ones post.